CWGCX | MWEMX | CWGCX / MWEMX | |
Total Expense Ratio | 1.49 | 0.81 | 184% |
Annual Report Gross Expense Ratio | 1.49 | 0.84 | 177% |
Fund Existence | 25 years | 13 years | - |
Gain YTD | 19.426 | 10.354 | 188% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 141B | 2.12B | 6,667% |
Annual Yield % from dividends | 0.77 | 1.00 | 76% |
Returns for 1 year | 10.05 | -6.64 | -151% |
Returns for 3 years | 63.73 | 10.56 | 603% |
Returns for 5 years | 46.65 | 2.74 | 1,702% |
Returns for 10 years | 72.38 | 46.48 | 156% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IJPTX | 12.35 | N/A | N/A |
VY® JPMorgan Emerging Markets Equity S2 | |||
FGTAX | 29.54 | N/A | N/A |
Fidelity Advisor Mega Cap Stock A | |||
VCIGX | 13.25 | N/A | N/A |
VALIC Company I Dividend Value | |||
ETAHX | 41.66 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
MSBVX | 11.48 | N/A | N/A |
Morgan Stanley American Resilience I |